Literature DB >> 29937048

Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection.

Chun-Hao Huang1, Ko-Chuan Lee1, Jennifer A Doudna2.   

Abstract

Cancer is a complex disease caused by combinations of cellular genetic alterations and heterogeneous microenvironments. The use of the robust and programmable CRISPR-Cas systems has greatly improved genome editing for precision cancer modeling and enabled multiplexed genetic manipulation for cancer treatment and mutation detection. In this review, we outline the current CRISPR-Cas toolkit, and discuss the promises and hurdles in translating this revolutionary technology into effective and safe clinical applications for cancer treatment and diagnosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2018        PMID： 29937048      PMCID： PMC6299457          DOI： 10.1016/j.trecan.2018.05.006

Source DB:  PubMed          Journal:  Trends Cancer        ISSN： 2405-8025


  112 in total

1.  CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations.

Authors:  Cem Kuscu; Mahmut Parlak; Turan Tufan; Jiekun Yang; Karol Szlachta; Xiaolong Wei; Rashad Mammadov; Mazhar Adli
Journal:  Nat Methods       Date:  2017-06-05       Impact factor: 28.547

2.  Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.

Authors:  Alexander M Aravanis; Mark Lee; Richard D Klausner
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

3.  E-CRISP: fast CRISPR target site identification.

Authors:  Florian Heigwer; Grainne Kerr; Michael Boutros
Journal:  Nat Methods       Date:  2014-02       Impact factor: 28.547

Review 4.  A guide to genome engineering with programmable nucleases.

Authors:  Hyongbum Kim; Jin-Soo Kim
Journal:  Nat Rev Genet       Date:  2014-04-02       Impact factor: 53.242

Review 5.  A chemical probe toolbox for dissecting the cancer epigenome.

Authors:  Jake Shortt; Christopher J Ott; Ricky W Johnstone; James E Bradner
Journal:  Nat Rev Cancer       Date:  2017-02-23       Impact factor: 60.716

6.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

7.  RNA targeting with CRISPR-Cas13.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Patrick Essletzbichler; Shuo Han; Julia Joung; Joseph J Belanto; Vanessa Verdine; David B T Cox; Max J Kellner; Aviv Regev; Eric S Lander; Daniel F Voytas; Alice Y Ting; Feng Zhang
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

8.  Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing.

Authors:  Nicola Crosetto; Abhishek Mitra; Maria Joao Silva; Magda Bienko; Norbert Dojer; Qi Wang; Elif Karaca; Roberto Chiarle; Magdalena Skrzypczak; Krzysztof Ginalski; Philippe Pasero; Maga Rowicka; Ivan Dikic
Journal:  Nat Methods       Date:  2013-03-17       Impact factor: 28.547

9.  High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity.

Authors:  Vikram Pattanayak; Steven Lin; John P Guilinger; Enbo Ma; Jennifer A Doudna; David R Liu
Journal:  Nat Biotechnol       Date:  2013-08-11       Impact factor: 54.908

10.  Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.

Authors:  Steven Lin; Brett T Staahl; Ravi K Alla; Jennifer A Doudna
Journal:  Elife       Date:  2014-12-15       Impact factor: 8.140
View more
  22 in total

1.  Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing.

Authors:  Sundaram Acharya; Arpit Mishra; Deepanjan Paul; Asgar Hussain Ansari; Mohd Azhar; Manoj Kumar; Riya Rauthan; Namrata Sharma; Meghali Aich; Dipanjali Sinha; Saumya Sharma; Shivani Jain; Arjun Ray; Suman Jain; Sivaprakash Ramalingam; Souvik Maiti; Debojyoti Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

2.  CRISPR/Cas12a Coupled With Recombinase Polymerase Amplification for Sensitive and Specific Detection of Aphelenchoides besseyi.

Authors:  Anpeng Zhang; Bin Sun; Jianming Zhang; Can Cheng; Jihua Zhou; Fuan Niu; Zhongyong Luo; Luzhen Yu; Cui Yu; Yuting Dai; Kaizhen Xie; Qiyan Hu; Yue Qiu; Liming Cao; Huangwei Chu
Journal:  Front Bioeng Biotechnol       Date:  2022-06-30

3.  Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy.

Authors:  Sameer Quazi
Journal:  Mol Biol Rep       Date:  2022-02-05       Impact factor: 2.742

4.  CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy.

Authors:  Rachel L Mintz; Madeleine A Gao; Kahmun Lo; Yeh-Hsing Lao; Mingqiang Li; Kam W Leong
Journal:  Adv Biosyst       Date:  2018-08-17

5.  A CRISPR Odyssey into Cancer Immunotherapy.

Authors:  Elizabeth Delgado; Samira Kiani
Journal:  CRISPR J       Date:  2020-04

6.  Argonaute integrated single-tube PCR system enables supersensitive detection of rare mutations.

Authors:  Qian Liu; Xiang Guo; Guanhua Xun; Zhonglei Li; Yuesheng Chong; Litao Yang; Hongxia Wang; Fengchun Zhang; Shukun Luo; Li Cui; Pengshu Zhao; Xingyu Ye; Heshan Xu; Hui Lu; Xiao Li; Zixin Deng; Kai Li; Yan Feng
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

Review 7.  Small nucleic acids and the path to the clinic for anti-CRISPR.

Authors:  Christopher L Barkau; Daniel O'Reilly; Seth B Eddington; Masad J Damha; Keith T Gagnon
Journal:  Biochem Pharmacol       Date:  2021-02-27       Impact factor: 6.100

Review 8.  SHERLOCK and DETECTR: CRISPR-Cas Systems as Potential Rapid Diagnostic Tools for Emerging Infectious Diseases.

Authors:  Mujahed I Mustafa; Abdelrafie M Makhawi
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

Review 9.  CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases.

Authors:  Somayeh Jolany Vangah; Camellia Katalani; Hannah A Booneh; Abbas Hajizade; Adna Sijercic; Gholamreza Ahmadian
Journal:  Biol Proced Online       Date:  2020-09-14       Impact factor: 3.244

Review 10.  Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.

Authors:  Shao-Shuai Wu; Qing-Cui Li; Chang-Qing Yin; Wen Xue; Chun-Qing Song
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.